Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program aims to help parents with advanced cancer talk to their kids

NCT ID NCT05477784

First seen Jan 25, 2026 · Last updated Jun 22, 2026 · Updated 24 times

Summary

This study tested two educational programs for parents with late-stage cancer who have children aged 5 to 17. The programs were designed to improve parent-child communication and boost parents' confidence in managing the impact of cancer on their children. The goal was to reduce anxiety and depression and improve quality of life for the whole family. The trial was terminated early, so the full results are not available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    Seattle, Washington, 98115, United States

  • Georgetown University

    Washington D.C., District of Columbia, 20007, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Educational program

What this could lead to

If successful, this program could provide a practical way to help parents with advanced cancer support their children's emotional health and reduce family distress.

What could go wrong

The trial was terminated early, so results are limited. It is a small, early-stage study, and the benefits may not apply to all families or cancer types.

Conditions

The condition(s) this trial relates to.

cancer hematopoietic and lymphoid system neoplasm neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.